Patients at high risk for PCP, specifically HIV-infected patients with CD4+ T-lymphocyte counts of less than 200 cells/mm3 and all AIDS patients who have already had one or more episodes of PCP receive prophylaxis with TMP-SMX and aerosolized pentamidine (18). Here, CD4 is linked to pneumocystosis.